Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial of Cilostazol for Prevention of Conversion From Mild Cognitive Impairment to Dementia

NCT02491268 is registered in ClinicalTrials.gov with National Cerebral and Cardiovascular Center, Japan as lead sponsor.

NCT NCT02491268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02491268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial of Cilostazol for Prevention of Conversion From Mild Cognitive Impairment to Dementia
Lead sponsor
National Cerebral and Cardiovascular Center, Japan
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2015
Completion date
December 1, 2020
Enrollment
166 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment